IN8bio, Inc. (INAB) vs Pulsenmore Ltd. Ordinary Shares (PLSM)
A side-by-side comparison of IN8bio, Inc. and Pulsenmore Ltd. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INAB
IN8bio, Inc.
$1.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLSM
Pulsenmore Ltd. Ordinary Shares
$2.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INAB vs PLSM
growth of $100 · dividends reinvested · last 1yINAB -39.8% (-39.8%/yr)PLSM -70.0% (-70.0%/yr)INAB compounded faster over this window
INAB PLSM
INAB vs PLSM: by the numbers
- •PLSM is the larger company ($14M vs $13M market cap).
- •Both run net losses; INAB's is the smaller (0.00% vs -39.61% net margin).
Metrics side by side
Valuation
| Metric | INAB | PLSM |
|---|---|---|
| P/B ratio | 0.73 | 0.86 |
Profitability
| Metric | INAB | PLSM |
|---|---|---|
| Gross margin | 0.00% | 84.15% |
| Operating margin | 0.00% | -30.39% |
| Net margin | 0.00% | -39.61% |
| ROE | -101.66% | -19.08% |
| ROIC | -91.74% | -13.15% |
Growth (annualized)
| Metric | INAB | PLSM |
|---|---|---|
| Total return CAGR (5Y) | -62.88% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.